Taiwan strengthens UK links as it adopts HTA approach
This article was originally published in Scrip
In a sign that Taiwan may be preparing to take on board more ideas from the UK in the areas of drug regulation and possibly health technology assessment, the East Asian island's Food and Drug Administration has signed a formal memorandum of co-operation with the UK Medicines and Healthcare Products Regulatory Agency (MHRA).
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.